RRx-001-Mediated Neuroprotection

Neurodegenerative diseases like ALS/MND, Parkinson’s Disease, Neurodegenerative diseases like ALS/MND, Parkinson’s Disease, central nervous system (CNS) toxicities and other related conditions are on the rise. Of the several mostly single-targeted pharmaceutical interventions that have been developed, none stop or reverse disease progression.

In contrast, RRx-001 (nibrozetone) is a multitargeted, Swiss-army-like neuroprotector that crosses the blood brain barrier (BBB) and defends the CNS against several of the pathological hallmarks that are common to chronic neurodegenerative disorders.

The effects of RRx-001 on the CNS are summarized below:

EpicentRx, in collaboration with Dr. Richard Gordon, renowned neuroinflammation expert from Brisbane, Australia, has also been awarded several grants to study RRx-001 in ALS/MND, CNS toxicities and other related conditions.